Reggie the Red Blood Cell Reggie the Red Blood Cell Join Reggie, our curious red blood cell, on a journey exploring connections between the heart, kidneys and pancreas.
World-Psoriasis-Day-IFPA-Interview World-Psoriasis-Day-IFPA-Interview Interview with the International Federation of Psoriasis Associations (IFPA)
Groundbreaking oncology research zongertinib Groundbreaking oncology research zongertinib Boehringer Ingelheim to unveil groundbreaking oncology research at WCLC, demonstrating strength of portfolio
Boehringer-Ingelheim's-half-year-figures-2021 Boehringer-Ingelheim's-half-year-figures-2021 Press release on Boehringer Ingelheim's half-year figures 2021. Business development from January to June 2021.
Acquisition Saint-Herblon site and Coophavet brand Acquisition Saint-Herblon site and Coophavet brand Boehringer Ingelheim and Dopharma complete the acquisition of Saint-Herblon production site
History video History video Learn more about the history of the innovative pharmaceutical company Boehringer Ingelheim
Streetvet: Free veterinary care Streetvet: Free veterinary care Learn more about StreetVet free veterinarian care for companion animals of the homeless
Zongertinib positive results non-small cell lung cancer Zongertinib positive results non-small cell lung cancer Boehringer’s zongertinib shows encouraging efficacy and tolerability profile in previously treated HER2 mutated lung cancer patients
Building Lasting Partnerships for a Better Future Building Lasting Partnerships for a Better Future Working with the University of Georgia, we’ve co-created a sustainability training initiative that benefits people, animals and the planet.
Boehringer Ingelheim acquires Nerio Therapeutics Boehringer Ingelheim acquires Nerio Therapeutics Today marks a significant step for Boehringer Ingelheim’s immuno-oncology pipeline by adding an innovative preclinical program with the acquisition of Nerio Therapeutics
Generalized pustular psoriasis is not ‘sensitive’ content Generalized pustular psoriasis is not ‘sensitive’ content Learn about the impact that a lack of online visibility can have on people living with this chronic, inflammatory skin disease.
Lung Repair & Regeneration Video Lung Repair & Regeneration Video Lung repair & regeneration research addresses fundamental changes to lung architecture and how these changes impact lung function.
Sore Mouth or Throat Sore Mouth or Throat Discover tips on how to take care of a sore mouth or throat from Taking Cancer On Through Flavour
Veganism Veganism Hear an expert’s opinion on the proposed link between a vegan diet and cancer recurrence rates.
Roasted Eggplant Fan Video Roasted Eggplant Fan Video Find out how this simple plant-based meal from Taking Cancer on Through Flavour and Taste Life are made
Ivan Blanarik Therapeutic Area Head Respiratory Ivan Blanarik Therapeutic Area Head Respiratory Ivan Blanarik, Therapeutic Area Head Respiratory at Boehringer Ingelheim
Four Pillars Cancer Immunology Four Pillars Cancer Immunology Boehringer Ingelheim is focusing cancer immunology research on T cell engagers, cancer vaccines, oncolytic viruses and immune & stromal modulation
Research-collaboration-Gubra-obesity-treatment Research-collaboration-Gubra-obesity-treatment Boehringer Ingelheim and Gubra enter collaboration to identify and validate targets and innovative peptides for the treatment of obesity.
reduced-heart-failure-treatment-approval-europe reduced-heart-failure-treatment-approval-europe European approval for treatment of adults with heart failure with reduced ejection fraction
real-world-benefit-shown-in-T2D-treatment real-world-benefit-shown-in-T2D-treatment Real-world evidence study shows type 2 diabetes treatment reduced risk of cardiovascular events and hospitalization for heart failure
empa-reg-outcome-recurrent-events empa-reg-outcome-recurrent-events EMPA-REG OUTCOME® analysis: Empagliflozin reduced risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and CV disease